Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization

Table 3 Remission and recurrence of hepatic cancer patients undergoing hepatic artery embolization chemotherapy (transcatheter arterial chemoembolization)

Group	Remission	Relapse	χ2	P value
Classification of HCC			9.44	< 0.05
Massive type, n = 71	58	13
Nodular type, n = 80	47	33
Diffuse type, n = 11	7	4
Preoperative staging			30.59	< 0.05
II stage, n = 97	83	14
III stage, n = 65	29	36
Child-Pugh			60.08	< 0.05
Child A, n = 42	34	8
Child B, n = 88	74	14
Child C, n = 32	4	28
AFP level			0.87	> 0.05
> 400 ng/mL, n = 124	86	38
20-400 ng/mL, n = 10	8	2
< 20 ng/mL, n = 28	18	10

HCC: Hepatocellular carcinoma; AFP: Alpha fetoprotein.